Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
Journal article
Authors / Editors
Research Areas
No matching items found.
Publication Details
Author list: Moyo S, Gaseitsiwe S, Powis KM, Pretorius Holme M, Mohammed T, Zahralban-Steele M, Yankinde EK, Maphorisa C, Abrams W, Lebelonyane R, Manyake K, Sekoto T, Mmalane M, Gaolathe T, Wirth KE, Makhema J, Lockman S, Clarke W, Essex M, Novitsky V
Publisher: Lippincott, Williams & Wilkins
Publication year: 2018
Journal: AIDS (0269-9370)
Journal acronym: AIDS
Volume number: 32
Issue number: 11
Start page: 1543
End page: 1546
Number of pages: 4
ISSN: 0269-9370
eISSN: 1473-5571
Languages: English-Great Britain (EN-GB)
Abstract
: Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use and were tested for viral load (n = 951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.
Keywords
No matching items found.
Documents
No matching items found.
